Dissemin is shutting down on January 1st, 2025

Published in

Lippincott, Williams & Wilkins, Journal of Cardiovascular Pharmacology, 6(83), p. 491-502, 2024

DOI: 10.1097/fjc.0000000000001494

Links

Tools

Export citation

Search in Google Scholar

Evaluation and Management of Pericarditis in Rheumatic Diseases

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

This review summarizes the evaluation for underlying rheumatic conditions in patients presenting with acute pericarditis, treatment considerations for specific rheumatic conditions, and the role of imaging in diagnosis and monitoring. Pericarditis may be one of the initial presentations of a rheumatic disease or identified in a patient with known rheumatic disease. There is also growing evidence for using anti-inflammatory and immunosuppressive agents for treating recurrent pericarditis, which can overlap with the treatment of rheumatic diseases.